These findings provide evidence that CTRP9 and its related signaling maybe a novel therapeutic target in improving cardiac function and alleviating the heart failure (HF) phenotype in MI patients with obstructive sleep apnea (OSA). The gene discussed is C1QTNF9; the disease is myocardial infarction.